{"id":50129,"date":"2022-10-26T23:02:02","date_gmt":"2022-10-26T21:02:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/"},"modified":"2022-10-26T23:02:02","modified_gmt":"2022-10-26T21:02:02","slug":"docgo-to-announce-third-quarter-2022-results-on-monday-november-7","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/","title":{"rendered":"DocGo to Announce Third Quarter 2022 Results on Monday, November 7"},"content":{"rendered":"
\n

\nManagement to host investor conference call and webcast at 5:00pm ET on that day<\/i>\n<\/p>\n

NEW YORK–(BUSINESS WIRE)–DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the third quarter ended September 30, 2022, after the markets close on Monday, November 7. Management will host a conference call for analysts and investors at 5:00pm ET on that day.\n<\/p>\n

<\/a><\/p>\n

\nConference call and webcast details:
\n
<\/b>Monday, November 7, 5:00pm ET
\n
1-855-327-6837 (U.S.)
\n
1-631-891-4304 (international)
\n
Conference ID: 10020451
\n
The webcast can be accessed under Events on the Investors section of the company\u2019s website, https:\/\/ir.docgo.com\/<\/a>.\n<\/p>\n

\nAbout DocGo<\/b>\n<\/p>\n

\nDocGo is a leading provider of last-mile mobile care services. DocGo is disrupting the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo’s innovative technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient’s home or workplace. Together with DocGo’s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
Susan Donahue
\n
Skyya PR
\n
651-283-8700
\n
susan.donahue@skyya.com<\/a>\n<\/p>\n

\nInvestors:<\/b>
Mike Cole
\n
DocGo
\n
949-444-1341
\n
mike.cole@docgo.com<\/a>
ir@docgo.com<\/a>\n<\/p>\n

\nSteve Halper
\n
LifeSci Advisors
\n
646-876-6455
\n
shalper@lifesciadvisors.com<\/a>
ir@docgo.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Management to host investor conference call and webcast at 5:00pm ET on that day NEW YORK–(BUSINESS WIRE)–DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the third quarter ended September 30, 2022, after the markets close on Monday, November 7. Management will host a … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50129","6":"format-standard","7":"category-industry"},"yoast_head":"\nDocGo to Announce Third Quarter 2022 Results on Monday, November 7 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DocGo to Announce Third Quarter 2022 Results on Monday, November 7 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Management to host investor conference call and webcast at 5:00pm ET on that day NEW YORK–(BUSINESS WIRE)–DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the third quarter ended September 30, 2022, after the markets close on Monday, November 7. Management will host a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-26T21:02:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221026005734\/en\/1379198\/21\/DocGo_Primary_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"DocGo to Announce Third Quarter 2022 Results on Monday, November 7\",\"datePublished\":\"2022-10-26T21:02:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/\"},\"wordCount\":276,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005734\\\/en\\\/1379198\\\/21\\\/DocGo_Primary_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/\",\"name\":\"DocGo to Announce Third Quarter 2022 Results on Monday, November 7 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005734\\\/en\\\/1379198\\\/21\\\/DocGo_Primary_Logo.jpg\",\"datePublished\":\"2022-10-26T21:02:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005734\\\/en\\\/1379198\\\/21\\\/DocGo_Primary_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005734\\\/en\\\/1379198\\\/21\\\/DocGo_Primary_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DocGo to Announce Third Quarter 2022 Results on Monday, November 7\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DocGo to Announce Third Quarter 2022 Results on Monday, November 7 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/","og_locale":"en_US","og_type":"article","og_title":"DocGo to Announce Third Quarter 2022 Results on Monday, November 7 - Pharma Trend","og_description":"Management to host investor conference call and webcast at 5:00pm ET on that day NEW YORK–(BUSINESS WIRE)–DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the third quarter ended September 30, 2022, after the markets close on Monday, November 7. Management will host a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-26T21:02:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221026005734\/en\/1379198\/21\/DocGo_Primary_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"DocGo to Announce Third Quarter 2022 Results on Monday, November 7","datePublished":"2022-10-26T21:02:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/"},"wordCount":276,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221026005734\/en\/1379198\/21\/DocGo_Primary_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/","url":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/","name":"DocGo to Announce Third Quarter 2022 Results on Monday, November 7 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221026005734\/en\/1379198\/21\/DocGo_Primary_Logo.jpg","datePublished":"2022-10-26T21:02:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221026005734\/en\/1379198\/21\/DocGo_Primary_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221026005734\/en\/1379198\/21\/DocGo_Primary_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/docgo-to-announce-third-quarter-2022-results-on-monday-november-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"DocGo to Announce Third Quarter 2022 Results on Monday, November 7"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50129"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50129\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}